Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Share-based Compensation (2018 - 2019)

Historic Share-based Compensation for DiaMedica Therapeutics (DMAC) over the last 2 years, with Q4 2019 value amounting to $401000.0.

  • DiaMedica Therapeutics' Share-based Compensation rose 51692.31% to $401000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $1.2 million, marking a year-over-year increase of 8774.19%. This contributed to the annual value of $2.1 million for FY2024, which is 2388.59% up from last year.
  • According to the latest figures from Q4 2019, DiaMedica Therapeutics' Share-based Compensation is $401000.0, which was up 51692.31% from $451000.0 recorded in Q3 2019.
  • DiaMedica Therapeutics' 5-year Share-based Compensation high stood at $451000.0 for Q3 2019, and its period low was $65000.0 during Q4 2018.